Johnson & Johnson

Johnson & Johnson, founded in 1886 by three brothers, Robert, James, and Edward Johnson, started as a small family-owned business creating surgical dressings. It quickly evolved into a multinational healthcare company, pioneering breakthroughs in medical innovations, consumer products, and pharmaceuticals. The company has consistently prioritized branding and intellectual property to build consumer trust. As a healthcare giant, Johnson & Johnson's trademarks cover a broad spectrum, including medical devices, pharmaceuticals, and consumer health products.

Johnson & Johnson, being a leader in the healthcare industry, actively monitors its trademarks to ensure the integrity of its brand. In 2007, Johnson & Johnson and the American Red Cross engaged in a trademark dispute over the use of the red cross symbol. Johnson & Johnson claimed that the American Red Cross's commercial use of the red cross symbol on products like first aid kits and health and safety manuals violated Johnson & Johnson's exclusive rights to the symbol. The dispute was settled in 2008, with an agreement that limited the American Red Cross's use of the red cross symbol in connection with certain commercial products. In 2019, Johnson & Johnson filed a trademark infringement lawsuit against Actelion Pharmaceuticals, a Swiss biopharmaceutical company. The dispute centered around the use of the name "Opsiria" for a medication developed by Actelion to treat a specific heart condition. Johnson & Johnson argued that the name was too similar to its own heart failure drug, "Opsumit," leading to potential confusion among healthcare professionals and consumers.